RIYADH, Saudi Arabia and ISTANBUL and OXFORDSHIRE, United Kingdom, June 30, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced that they have been appointed by Immunocore (Nasdaq: IMCR) as the distribution and commercialization partner for KIMMTRAK, for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma, in Turkey and across the Middle East, North Africa, Caucasus and the ...

Key Takeaways GEHC received FDA approval to expand Vizamyl's label for beta-amyloid PET imaging and quantification. GE HealthCare can now use Vizamyl to monitor response to anti-amyloid therapies and diagnose Alzheimer's. GEHC expects broader Vizamyl use to support earlier diagnosis and more personalized treatment decisions.GE HealthCare Technologies Inc. (GEHC) has received the FDA’s approval for an updated label for its positron emission tomography (PET) imaging agent Vizamyl (flutemetamol F 18 injectio ...